We are also investigating the links between aging (and other metabolic diseases such as obesity and diabetes) on cancer initiation and progression. Utilizing state-of-the-art technologies, we observe and manipulate these pathways in a variety of cell-based and mouse models of cancer. Clinician-scientists in the lab then translate our findings in the clinic. Additionally, we have also established several collaborations with clinicians at New York-Presbyterian Hospital and Weill Cornell Medicine (WCM).

The Blenis Laboratory is a part of the Meyer Cancer Center at WCM, an established cancer center in the heart of NYC. Dr. Blenis is the Anna-Maria and Stephen Kellen Professor in Cancer Research, Associate Director for Basic Science at the Meyer Cancer Center, and Professor of Pharmacology at WCM. Dr. Blenis is affiliated with Tri-Institutional training programs (centered among three premier New York Institutions: Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and the Rockefeller University), and is a participating member of the Tri-Institutional PhD program in Chemical Biology and the Tri-Institutional MD-PhD Program.